WHO ICTRP trial
A clinical trial about the safety of 5 times amount intake of Chrysanthemum…
JPRN-UMIN000027214 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000027214 |
|---|---|
| Public title | A clinical trial about the safety of 5 times amount intake of Chrysanthemum Morifolium Flower extract |
| Scientific title | A clinical trial about the safety of 5 times amount intake of Chrysanthemum Morifolium Flower extract - A clinical trial about the safety of 5 times amount intake of Chrysanthemum Morifolium Flower extract |
| Primary sponsor | ORYZA OIL & FAT CHEMICAL CO., LTD. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | healthy subject |
| Interventions | 500mg/day Chrysanthemum Morifolium Flower extract supplementation (4 weeks) 500mg/day placebo supplementation (4 weeks) |
| Registration date | Jun 16, 2017 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: